Psoriasis, stress, age and more von Mrowietz, U.

Volltext

Psoriasis and multiple sclerosis: two diseases, one treatment von Mrowietz, U.

Volltext

Implementing treatment goals for successful long-term management of psoriasis von Mrowietz, U.

Volltext

Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management von Saunte, D.M., Mrowietz, U., Puig, L., Zachariae, C.

Volltext

Psoriasis: rationale for targeting interleukin-17 von Girolomoni, G., Mrowietz, U., Paul, C.

Volltext

European consensus statement on phenotypes of pustular psoriasis von Navarini, A.A., Burden, A.D., Capon, F., Mrowietz, U., Puig, L., Köks, S., Kingo, K., Smith, C., Barker, J.N., Bachelez, Hervé, Chiricozzi, Andrea, Costanzo, Antonio, Eyerich, Kilian, French, Lars E., Ghoreschi, Kamran, Gilliet, Michel, Girolomoni, Giampiero, Gniadecki, Robert, Griffiths, Christopher, Koh, Hong Yi, Lipsker, Dan, Naldi, Luigi, Prans, Ele, Prinz, Jörg, Reich, Kristian, Röcken, Martin, Skov, Lone, Sorin, George, Ståhle, Mona, Stingl, Georg, Van de Kerkhof, Peter, Warren, Richard

Volltext

Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation von Mrowietz, U., Sümbül, M., Gerdes, S.

Volltext

Definition of treatment goals for moderate to severe psoriasis: a European consensus von Mrowietz, U, Kragballe, K, Reich, K, Spuls, P, Griffiths, C. E. M, Nast, A, Franke, J, Antoniou, C, Arenberger, P, Balieva, F, Bylaite, M, Correia, O, Daudén, E, Gisondi, P, Iversen, L, Kemény, L, Lahfa, M, Nijsten, T, Rantanen, T, Reich, A, Rosenbach, T, Segaert, S, Smith, C, Talme, T, Volc-Platzer, B, Yawalkar, N

Volltext

Fumarates for psoriasis: new insights into a small molecule prototype von Mrowietz, U.

Volltext

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis von Egeberg, A., Gisondi, P., Carrascosa, J.M., Warren, R.B., Mrowietz, U.

Volltext

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled tri... von Paul, C., Cather, J., Gooderham, M., Poulin, Y., Mrowietz, U., Ferrandiz, C., Crowley, J., Hu, C., Stevens, R.M., Shah, K., Day, R.M., Girolomoni, G., Gottlieb, A.B.

Volltext

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC von Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.

Volltext

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial von Reich, K., Sullivan, J., Arenberger, P., Mrowietz, U., Jazayeri, S., Augustin, M., Parneix, A., Regnault, P., You, R., Milutinovic, M.

Volltext

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest von Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., Augustin, M.

Volltext

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Stu... von Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Lacombe, A., Xia, S., Mazur, R., Patekar, M., Charef, P., Milutinovic, M., Leonardi, C., Mrowietz, U.

Volltext

Clinical use of dimethyl fumarate in moderate‐to‐severe plaque‐type psoriasis: a European expert consensus von Mrowietz, U., Barker, J., Boehncke, W.‐H., Iversen, L., Kirby, B., Naldi, L., Reich, K., Tanew, A., Kerkhof, P.C.M., Warren, R.B.

Volltext

Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement von Morrison, P.J., Suhrkamp, I., Gerdes, S., Mrowietz, U.

Volltext

A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis von Mrowietz, U., de Jong, E.M.G.J., Kragballe, K., Langley, R., Nast, A., Puig, L., Reich, K., Schmitt, J., Warren, R.B.

Volltext

Perception and determinants of stigmatization of people with psoriasis in the German population von Sommer, R., Topp, J., Mrowietz, U., Zander, N., Augustin, M.

Volltext

Non-adherence and measures to improve adherence in the topical treatment of psoriasis von Zschocke, I., Mrowietz, U., Karakasili, E., Reich, K.

Volltext